FICI, PIETRO
FICI, PIETRO
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
2022 Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G.
Single-cell NGS-based analysis of copy number alterations reveals new insights in circulating tumor cells persistence in early-stage breast cancer
2020 Rossi T.; Gallerani G.; Angeli D.; Cocchi C.; Bandini E.; Fici P.; Gaudio M.; Martinelli G.; Rocca A.; Maltoni R.; Fabbri F.
Crowdfunding for cancer research: the TRACe campaign as an example
2019 Gallerani G.; Fici P.; Coatti A.; Mariotti P.; Passeri F.; Battistelli L.
Circulating tumor cells: Back to the future
2017 Gallerani G.; Fici P.; Fabbri F.
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
2017 Fici P.; Gallerani G.; Morel A.-P.; Mercatali L.; Ibrahim T.; Scarpi E.; Amadori D.; Puisieux A.; Rigaud M.; Fabbri F.
CTCs in early breast cancer: A path worth taking
2016 Maltoni R.; Gallerani G.; Fici P.; Rocca A.; Fabbri F.
Circulating tumor cells in early breast cancer: A connection with vascular invasion
2015 Maltoni R.; Fici P.; Amadori D.; Gallerani G.; Cocchi C.; Zoli M.; Rocca A.; Cecconetto L.; Folli S.; Scarpi E.; Serra P.; Fabbri F.
Epithelial Mesenchymal Transition: a double-edged sword
2015 Guislaine Barriere, Pietro Fici, Giulia Gallerani, Francesco Fabbri, Michel Rigaud
Circulating tumor cells and epithelial, mesenchymal and stemness markers: Characterization of cell subpopulations
2014 Barriere G.; Fici P.; Gallerani G.; Fabbri F.; Zoli W.; Rigaud M.
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
2013 Fabbri F.; Carloni S.; Zoli W.; Ulivi P.; Gallerani G.; Fici P.; Chiadini E.; Passardi A.; Frassineti G.L.; Ragazzini A.; Amadori D.